Th2 cytokines and asthma — Interleukin-9 as a therapeutic target for asthma
AUTOR(ES)
Zhou, Yuhong
FONTE
BioMed Central
RESUMO
Asthma is a complex heritable inflammatory disorder of the airways in which the development of clinical disease depends on environmental exposure. It has been well established that T helper type 2 (TH2) lymphocytes and their cytokines have an important role in allergic asthma. Interleukin (IL)-9, a member of the TH2 cytokine family, has recently been implicated as an essential factor in determining mucosal immunity and susceptibility to atopic asthma. In this review we examine the critical experiments and observations that support this hypothesis. We also discuss these results in comparison with the experiments supporting the involvement of other TH2 cytokines such as IL-4, IL-5 and IL-13.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=59572Documentos Relacionados
- Th2 cytokines and asthma — The role of interleukin-5 in allergic eosinophilic disease
- Th2 cytokines and asthma: an introduction
- Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists
- Expression of Interleukin-9 Leads to Th2 Cytokine-Dominated Responses and Fatal Enteropathy in Mice with Chronic Schistosoma mansoni Infections
- Th1 and Th2 cytokines in mice with invasive aspergillosis.
